Molecular mechanisms of basal and D-amphetamine (AMPH)-induced apoptosis were studied in rat liver nodules, 12 (N12) and 30 (N30) weeks after initiation, and in hepatocellular carcinoma (HCC) induced by diethylnitrosamine in rats subjected to resistant hepatocyte model. Basal apoptosis in hematoxylin/eosin-and propidium iodidestained sections was higher in nodules and HCC than in normal livers. It sharply increased in all tissues 4 hours after AMPH treatment (10 mg/kg), and declined to basal levels at 8 to 12 hours in liver and N12, but remained high up to 18 hours in N30 and HCC. c-myc, Tgf-␣, p53, and Bcl-X S messenger RNA (mRNA) levels were higher, and Bcl-2 mRNA was lower in N12 and/or N30 and HCC than in normal liver. Four hours after AMPH injection, increase in c-myc and decreases in Bcl-2 and Bcl-X L mRNAs occurred in all tissues, whereas p53, Bax, and Bcl-X S mRNAs increased in N30 and HCC. These changes disappeared in liver and N12 at 18 hours, but persisted in N30 and HCC. c-Myc, P53, Bcl-2, and Bax proteins in normal liver and HCC ؎ AMPH showed similar patterns. Tgf-1, Tgf--RIII, CD95, and CD95L mRNA levels underwent slight or no changes in any tissue ؎ AMPH. Basal Hsp27 expression was high in nodules and HCC, and was stimulated by AMPH in liver and N12, but not in N30 and HCC. These data suggest a role of dysregulation of Bcl-2 family genes and, at least in atypical lesions, of p53 overexpression, in basal and AMPHinduced apoptosis in nodules and HCCs. Hsp27 does not appear to sufficiently protect atypical lesions against apoptosis. (HEPATOLOGY 2000;31:956-965.)It is estimated that during rat liver carcinogenesis induced by chemicals, a number of initiated hepatocytes undergo apoptotic cell death. 1 Tumor promoters stimulate proliferation and inhibit apoptosis of initiated cells, thus inducing the development of preneoplastic foci of altered hepatocytes. Several studies have shown that the cessation of the administration of tumor promoters is followed up by enhanced apoptosis of hepatocytes in these lesions. [2][3][4][5][6] The molecular mechanisms underlying this phenomenon during the regression of liver hyperplasia induced by promoters have not yet been completely clarified, although a role of TGF-1 has been postulated. 5,6 Moreover, recent evidence indicates that the inhibition of apoptosis by nongenotoxic hepatocarcinogens is associated with overexpression of Bcl-2 and Bcl-X L . 7 The growth of initiated hepatocytes leads to the development of persistent liver nodules and hepatocellular carcinomas (HCCs). These lesions exhibit a high rate of cell proliferation and cell death by apoptosis, with a slight prevalence of cell production on cell loss, which allows their slow progression to more malignant stages. 1,4,8 Persistent nodules and HCCs are highly susceptible to some apoptosisinducing treatments, which can inhibit their evolution to more malignant stages. 4,9,10 The mechanisms underlying high constitutive apoptosis of chemically induced preneoplastic and neoplastic liver lesions, in vivo, a...